Peter W. Dettmar

Peter W. Dettmar

Castle Hill Hospital, Daisy Building, Castle Road, East Yorkshire
Cottingham, ENG HU165JQ, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

A Novel In Vitro Model for Determining the Optimum pH and Dose Volume of New Liquid Alginate for Infant Reflux Suppression.

A Novel In Vitro Model for Determining the Optimum pH and Dose Volume of New Liquid Alginate for Infant Reflux Suppression.

Journal: Drugs in R&D

Published: June 24, 2021

Pepsin and pH of Gastric Juice in Patients With Gastrointestinal Reflux Disease and Subgroups.

Pepsin and pH of Gastric Juice in Patients With Gastrointestinal Reflux Disease and Subgroups.

Journal: Journal of clinical gastroenterology

Published: September 14, 2020

Alginates: From the ocean to gastroesophageal reflux disease treatment.

Alginates: From the ocean to gastroesophageal reflux disease treatment.

Journal: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology

Published: October 19, 2019

Validation of Peptest™ in Patients with Gastro-Esophageal Reflux Disease and Laryngopharyngeal Reflux Undergoing Impedance Testing.

Validation of Peptest™ in Patients with Gastro-Esophageal Reflux Disease and Laryngopharyngeal Reflux Undergoing Impedance Testing.

Journal: Journal of gastrointestinal and liver diseases : JGLD

Published: August 06, 2019

Letter: studies of salivary pepsin in patients with gastro-oesophageal reflux disease.

Letter: studies of salivary pepsin in patients with gastro-oesophageal reflux disease.

Journal: Alimentary pharmacology & therapeutics

Published: April 13, 2019

Salivary Pepsin as an Intrinsic Marker for Diagnosis of Sub-types of Gastroesophageal Reflux Disease and Gastroesophageal Reflux Disease-related Disorders.

Salivary Pepsin as an Intrinsic Marker for Diagnosis of Sub-types of Gastroesophageal Reflux Disease and Gastroesophageal Reflux Disease-related Disorders.

Journal: Journal of neurogastroenterology and motility

Published: February 13, 2019

Validation in China of a non-invasive salivary pepsin biomarker containing two unique human pepsin monoclonal antibodies to diagnose gastroesophageal reflux disease.

Validation in China of a non-invasive salivary pepsin biomarker containing two unique human pepsin monoclonal antibodies to diagnose gastroesophageal reflux disease.

Journal: Journal of digestive diseases

Published: October 29, 2018

Pepsin: biomarker, mediator, and therapeutic target for reflux and aspiration.

Pepsin: biomarker, mediator, and therapeutic target for reflux and aspiration.

Journal: Annals of the New York Academy of Sciences

Published: January 03, 2018

A comparative study on the raft chemical properties of various alginate antacid raft-forming products.

A comparative study on the raft chemical properties of various alginate antacid raft-forming products.

Journal: Drug development and industrial pharmacy

Published: August 25, 2017

Association of Gel-Forming Mucins and Aquaporin Gene Expression With Hearing Loss, Effusion Viscosity, and Inflammation in Otitis Media With Effusion.

Association of Gel-Forming Mucins and Aquaporin Gene Expression With Hearing Loss, Effusion Viscosity, and Inflammation in Otitis Media With Effusion.

Journal: JAMA otolaryngology-- head & neck surgery

Published: June 09, 2017

Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation.

Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation.

Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

Published: March 30, 2016

Use of pepsin detection to identify airways reflux in a range of pulmonary diseases.

Use of pepsin detection to identify airways reflux in a range of pulmonary diseases.

Journal: The clinical respiratory journal

Published: September 26, 2015

Showing 1-12 of 27

Last Updated: 09/26/2026